Results 101 to 110 of about 2,229 (127)

Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience. [PDF]

Antibodies (Basel)
Markwitz M, Welc N, Kępińska K, Bowszyc-Dmochowska M, Dmochowski M.   +4 more
europepmc   +1 more source

Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series. [PDF]

J Dtsch Dermatol Ges
Yilmaz K, Goletz S, Hammers CM, Boch K, Zeidler C, Wiegmann H, Bergmann E, Lari TR, Dikmen O, Häring N, Strohal R, Kleinheinz A, Hadaschik EN, van Beek N, Ständer S, Schmidt E.   +15 more
europepmc   +1 more source

A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. [PDF]

Cureus
Palacio I, Arraut K, Portalatin K, Estil-Las AA, Grace M.   +4 more
europepmc   +1 more source

Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre. [PDF]

Antibodies (Basel)
Spałek MM, Jałowska M, Welc N, Bowszyc-Dmochowska M, Hashimoto T, Gornowicz-Porowska J, Dmochowski M.   +6 more
europepmc   +1 more source

A case of bullous pemphigoid in an ulcerative colitis patient treated with vedolizumab. [PDF]

JAAD Case Rep
Odom MB, Chen JN, Echavarria JF, Gilson RT.   +3 more
europepmc   +1 more source

Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue <i>COL17A1</i> mutations and dysregulation. [PDF]

JID Innov
Chang RC, Olbrich H, Wang YF, Gainer H, Curkovic N, Walunas TL, Shiu J, Goyal P, Mansini AP, Ludwig RJ, Amber KT.   +10 more
europepmc   +1 more source

Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series. [PDF]

Acta Derm Venereol
Tejero-García C, Alamon Reig F, Bosch-Amate X, Carrera C, Giavedoni P, Gil Faure I, Jiménez Antón A, Mayor Ibarguren A, Usero Bárcena T, Álvarez-Salafranca M, Gamissans Cañada M, López Robles J, Martínez-Fernández S, Segura S, Sánchez-Aguilar Rojas D, Flórez Á.   +15 more
europepmc   +1 more source

Case Report: Dupilumab therapy for immune checkpoint inhibitor-induced bullous pemphigoid enables dual immunotherapy initiation in progressive malignant melanoma. [PDF]

Front Oncol
Grüninger J, Lehr S, Meiss F, Rafei D, Schauer F.   +4 more
europepmc   +1 more source

Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy. [PDF]

Clin Case Rep
Wang F, Li H, Xu Y, Wang W.
europepmc   +1 more source